You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Bottom Water Temperature and Pressure Sensor with Real-time Readout
SBC: AVS US INC Topic: 834Monitors that are currently used to periodically record bottom water temperatures cannot be read by the lobstermen who use them. In addition, current monitors make no provision for recording changes in depth if they are redeployed in a different location. The specific aim of this proposal is to develop a sensor that will measure water temperature and pressure hourly and will be readable by a rad ...
SBIR Phase I 2004 Department of Commerce -
EFFICIENT & EFFECTIVE MOBILE DATA CAPTURE IN AN ACRIN CLIN TRIAL ENVIRON
SBC: ADVANCED DIGITAL SYSTEMS, INC. Topic: N/AN/A
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Nanoliter Lab-on-a-Chip for Blood Diagnostics
SBC: ADVANCED LIQUID LOGIC Topic: N/ADESCRIPTION (provided by applicant): Large volumes of blood (milliliters) are required for diagnostics with large instruments, latrogenic blood loss or "bleeding into the laboratory" is an important reason for administration of small volume transfusions i
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Nanoliter Lab-on-a-chip for Protein Crystallization
SBC: ADVANCED LIQUID LOGIC Topic: N/ADESCRIPTION (provided by applicant): The human genome contains at least 30,000 unique open reading frames that may yield >100,000 polypeptide products. These products assemble into more than a million biologically relevant structures of interest per organ
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Innovation Tools for the Molecular Diagnosis of Cancer
SBC: ALDERON BIOSCIENCES, INC. Topic: N/ADESCRIPTION (provided by applicant): Current treatment of cancer patients relies on establishing an accurate diagnosis using a complex combination of clinical and histopathological data but in some instances accurate diagnosis is difficult or impossible
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Device for Rapid Gene Detection of Multiple Bio-Agents
SBC: ALDERON BIOSCIENCES, INC. Topic: N/ADESCRIPTION (provided by applicant): Despite our progress in combating infectious diseases during the last century, many of those diseases still represent major threats. Moreover, we now have the technical capability to render those diseases even more dangerous, and the potential for biological agents to be used as weapons has become all too real. Military and civilian personnel alike are at risk. ...
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Resolving Biological Entity References (Text/Databases)
SBC: ALIAS-I Topic: N/ADESCRIPTION (provided by applicant): In the broadest terms, the goal of the proposed work is to make it easier for researchers to apply robust, scalable, entity-centered, heterogeneous data access to the biomedical literature. 'Entity centered' means th
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Kidney Preservation for Transplantation
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): Renal transplantation is the most effective and cost efficient treatment for patients with established renal disease. However ischemia-reperfusion injury associated with the retrieval, storage and transplantation of ki
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Therapeutic Potential of Refanalin in Pulmonary Fibrosis
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): Idiopathic pulmonary fibrosis (IPF) is a devastating disease with less than a 50% five-year survival. While steroids and other immunosuppressive agents serve as the standard treatment for IPF, these agents have pro
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Protection from Stroke by SF/HGF-like Small Molecule
SBC: Angion Biomedica Corp. Topic: N/ADESCRIPTION (provided by applicant): Atherosclerosis of the cerebral vasculature can produce occlusion and cerebral infarction. Although the tissue in the ischemia core dies within minutes, the surrounding tissue, termed the ischemic penumbra, sustain
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health